Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

ZOLMITRIPTAN TABLET

Active
SPE2DP-26-T-4332Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Zolmitriptan tablets, 2.5 mg film-coated, are supplied in blister packs containing six tablets per package, with the unit of issue defined as a package of six units. The product must be stored at controlled room temperature and marked in accordance with the latest edition of the Medical Marking Standard No. 1, adhering to DLA packaging requirements and technical quality standards as outlined in the DLA Master List of Technical and Quality Requirements. The item is classified as a Type I (Code Q) drug with a non-extendable shelf life of 36 months, and all supplies must comply with removal of government identification if not accepted, with potential application of Covered Defense Information protocols. The contract specifies two manufacturer part numbers—NDC71626-0101-06 from Medstone Pharma LLC and NDC60846-0130-30 from Amneal Pharmaceuticals of New York, LLC—both subject to FDA regulation and requiring prior confirmation via EBS referral by the contracting official. The delivery instruction requires FOB destination within 20 days, with no variance allowed in quantity, inspection and acceptance occurring at the delivery point, and packaging must meet MIL-STD-2073-1E standards. The contract, issued under solicitation SPE2DP-26-T-4332, has a posted date of July 28, 2026, and a response deadline of August 3, 2026, with three packages totaling 18 tablets ordered at $3.00 per package. The item is linked to NSN 6505015232352 and classified under NAICS code 325412 for pharmaceutical manufacturing.

General Info

2.5 mg zolmitriptan tablets, 6 per package, FOB destination, 36-month shelf life, two approved manufacturers, $3.00 per package.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4332.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
JAMES FOGGIE
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
ZOLMITRIPTAN TABLET
ZOLMITRIPTAN TABLETS
.
2.5MG<(>,<)> BLISTER PACK, FILM-COATED TABLETS. 6S
.
UNIT OF ISSUE: PACKAGE (PG) OF 6EA
.
STORE AT CONTROLLED ROOM TEMPERATURE
.
SHALL BE MARKED IAW THE LATEST EDITION OF MEDICAL MARKING STANDARD NO. 1
HTTPS://WWW.DLA.MIL/LOGISTICS-OPERATIONS/PACKAGING/
.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 PG = 6 EA .. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
MEDSTONE PHARMA LLC 89LP5 P/N NDC71626-0101-06 AMNEAL PHARMACEUTICALS OF NEW YORK, LLC 557X3 P/N NDC60846-0130-30
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017631631 0001 PG 3.000
SPE2DP-26-T-4332
SECTION B
PR: 7017631631 PRLI: 0001 CONT’D
NSN/MATERIAL:6505015232352
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-523-2352 Quantity: 3 PG Purchase Request: 7017631631QTY: 3 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
ZINC OXIDE OINTMENTZINC OXIDE OINTMENT USP, containing 20% zinc oxide in a 1-ounce collapsible tube weighing 28.35 grams, is procured as a topical skin protectant under contract SPE2DP-26-T-4335. The item is regulated by the FDA and must comply with all applicable DLA Master List of Technical and Quality Requirements, including packaging standards per MIL-STD-129 and DLA Packaging Requirements for Procurement RP001. The product requires storage at controlled room temperature not exceeding 30°C (86°F) and has a non-extendable shelf life of 36 months as a TYPE I (CODE Q) item. All packaging must be marked in accordance with the latest Medical Marking Standard No. 1 and labeled with the NDC number 67777-0223-11. The unit of issue is the tube (TU), and no variance in quantity is permitted. The contract includes two line items totaling 14 tubes: 10 tubes delivered to a location in Richmond, Virginia, and 4 tubes delivered to Melrose, Massachusetts. Both deliveries are FOB destination with a five-day delivery window and must be shipped via traceable means—parcel post is prohibited. Packaging must adhere to ASTM D3951 if not classified as hazardous under FED-STD-313, but DLA requirements override any conflicting standards. Palletization follows RP001 guidelines, and all shipments must include proper government identification markings. The original required delivery dates are July 29, 2026, and July 30, 2026, respectively. The contract specifies a unit price of $1.00 per tube with no total price variation, and it is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with James McCullough as the primary point of contact.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
RINGER'S INJECTION, LACRINGER'S INJECTION, LACTATED, USP, 1000ML in packs of 12 units per case, is being procured under contract SPE2DP-26-T-4338 with a total quantity of 3 cases, each containing 12 units, for delivery to Bogalusa, LA within five days under FOB destination terms. The product must be packaged in sealed unit containers that protect against damage and shipped in commercial exterior containers suitable for safe transport by common carrier at the lowest cost, conforming to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The item, manufactured by B. BROWN MEDICAL INC with NDC 00264-7750-00, has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C) with brief exposure up to 40°C permitted; freezing and excessive heat must be avoided. All packaging and labeling must adhere to the latest version of the Medical Marking Standard No. 1, available through DLA Troop Support, and technical and quality requirements referenced by R or I numbers are governed by the DLA Master List in effect at the solicitation or award date. The contract specifies zero variance in quantity, inspection and acceptance occur at delivery point, and government identification must be removed from non-accepted supplies. The FDA regulates this drug, requiring buyer referral via EBS to the product specialist, including manufacturer and bidder details. The purchase is under the DoD unit of issue system, and procurement falls under NAICS 325412.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
EMOLLIENT LOTIONThe contract specifies the procurement of 2 bottles of Emollient Lotion, each containing 240 mL (8 FL OZ), packaged in a non-sterile bottle with a dispenser cap. The lotion must be an oil-in-water or water-in-oil emulsion containing a minimum of water, a suitable oil, an emulsifier, and a preservative, with additional compliant ingredients such as stabilizers, thickening agents, emollients, surfactants, humectants, colorants, and fragrances permitted in sufficient quantities. It must maintain a pH between 5.0 and 8.1 and exhibit a viscosity of 10,000 to 20,000 CPS at 25°C when measured with a Brookfield Viscometer Model LVT using Spindle No. 13 at 6 RPM. The product is regulated by the FDA and must be stored at controlled room temperature. Packaging and marking must comply with the latest Medical Marking Standard No. 1 and MIL-STD-129, with commercial packaging adhering to ASTM D3951 unless superseded by stricter DLA requirements. The unit of issue is a bottle (BT), and delivery is required FOB destination within 20 days of contract award to a military installation at Fort Bliss, Texas. No quantity variance is permitted, and inspection and acceptance occur at the destination. Traceable shipping methods are mandatory, and parcel post is prohibited. The contract reference number is SPE2DP-26-T-4329, with a required delivery date of July 29, 2026, and the product is identified by NSN 6508-01-019-7181. The supplier must meet all technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
DEXTROSE INJECTIONDextrose Injection 5% USP is a sterile, nonpyrogenic, intravenous solution supplied in 1000 mL single-dose plastic bags, each containing 50 grams of anhydrous dextrose USP and water for injection USP. The product is latex-free and intended solely for intravenous administration. It is packaged in units of 12 bags per package, with a non-extendable shelf life of 30 months and must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), protected from freezing and excessive heat. Packaging and marking must comply with the latest edition of the Medical Marking Standard No. 1 and MIL-STD-2073-1E, with government identification removed from non-accepted supplies. The item is classified as a TYPE I (CODE P) product under DLA’s technical and quality requirements, which are governed by the DLA Master List referenced in the solicitation. The contract specifies a delivery requirement of five days FOB destination, with zero variance allowed in quantity, and inspection and acceptance occurring at the delivery point. The supply is identified by NSN 6505013306252 and NDC codes corresponding to manufacturers ICU Medical, Inc. and B. Braun Medical Inc. The solicitation number is SPE2DP-26-T-4336, issued by the Department of Defense through the Medical Supply Chain Pharma FSA, with bids due by August 3, 2026, and a total contracted quantity of two packages, amounting to 24 bags.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE CLEANSPOVIDONE-IODINE CLEANSING SOLUTION, USP, with 7.5% active ingredient, is procured for external use only in 1-gallon bottles designated as Unit of Issue BT, with a total shelf life of 36 months and a minimum of 31 months remaining at the time of delivery to the first government activity. The product must be stored at 25°C (77°F), with permitted excursions between 15°C and 30°C (59°F–86°F). It is regulated by the FDA and classified as a hazardous material under Federal Standard No. 313-E, requiring compliance with OSHA’s updated Hazard Communication Standard, including submission of Safety Data Sheets and GHS-compliant labels prior to award. All packaging and marking must conform to Medical Marking Standard No. 1, superseding MIL-STD-129, and adhere to DLA Packaging Requirements for Procurement, including palletization and commercial packaging per ASTM D3951 unless overridden by applicable DLA technical requirements. The item is supplied by Cardinal Health 200, LLC and Purdue Pharma LP under NDC 67618-0151-01. The contract requires six deliveries totaling 13 BT (bottles) to various U.S. Navy vessels and support units, with delivery scheduled within 30 days after award date. Each shipment is addressed to specific FPO locations and must be transported by traceable means via VSM; parcel post is prohibited. Pricing is firm fixed with zero variance tolerance, inspection and acceptance occur at destination, and FOB terms are destination. The solicitation, SPE2DP-26-Q-0122, incorporates mandatory technical and quality requirements from the DLA Master List, and includes federal clauses on veteran employment reporting, sustainable products, and wide area workflow payment. Delivery deadlines for individual line items range from May to June 2026, with all shipments subject to strict compliance with government-specific logistics and regulatory standards.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
TOLNAFTATE POWDER, UTolnaftate Powder USP 1% in 45 gram units is being procured under solicitation SPE2DP-26-T-4337 by the Department of Defense through the Medical Supply Chain Pharmaceutical FSA, with delivery required to Pearl Harbor, Hawaii. The contract specifies two quantities: two units and twenty units, each unit defined as one 45 gram container, with a total order value based on fixed unit pricing and no variance allowed in quantity. The material must be packaged in commercial containers that protect against damage and meet the Medical Marking Standard No. 1, which supersedes MIL-STD-129, and palletization must comply with DLA Packaging Requirements for Procurement. The product has a non-extendable shelf life of 36 months and is not classified as hazardous under FED-STD-313, so it must be packaged per ASTM D3951, though all DLA Master List technical and quality requirements take precedence over commercial standards. Shipments must be traceable and cannot use parcel post; delivery is FOB destination with inspection and acceptance occurring at the final delivery point. The required delivery window is 20 days from the contract’s award, with an original delivery deadline of July 30, 2026. The supplier is Geri-Care Pharmaceuticals Corp. with NDC code 57896-0199-45 and the product is identified by NSN 6505-01-480-7897, while all packaging and labeling must conform to DLA’s current medical and logistics directives.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
BUTORPHANOL TARTRATE IButorphanol Tartrate Injection, Veterinary, is a Schedule IV controlled substance containing 10 mg of butorphanol per milliliter, approved for pain relief associated with colic in adult horses and yearlings. The product is supplied in 50 mL vials, with a total contract quantity of eight vials, and must be stored at controlled room temperature between 20–25°C (68–77°F) in a secured location due to its controlled substance classification. Once first punctured, the contents must be used within four months, and the item carries a non-extendable shelf life of 24 months under the Type I (Code M) requirement. The packaging and marking must comply with the latest Medical Marking Standard No. 1 and MIL-STD-2073-1E, and all government identification must be removed from non-accepted supplies per RQ011. The item is regulated by the FDA, and buyers are required to submit a referral via EBS with full manufacturer and product details for confirmation prior to award. The contract is issued under solicitation SPE2DP-26-T-4341 with delivery due in 89 days FOB destination, and no quantity variance is permitted. Approved manufacturers include Zoetis Inc., Patterson Veterinary Supply, and Covetrus North America, LLC, each with specified part numbers and NDC codes. The procurement is managed by the Department of Defense through the Medical Supply Chain Pharm FSA, with Shairy M. Cartagena as the primary point of contact.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE CLEANSPovidone-Iodine Cleansing Solution, USP, with 7.5% active ingredient, is procured for external use only in 1-gallon bottles under the unit of issue BT, with each BT representing three units. The product has a non-extendable shelf life of 36 months, and at least 31 months must remain upon delivery to the first government activity. Storage requirements specify 25°C (77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F). The solution is regulated by the FDA and classified as a hazardous material under Fed-Std-313, requiring compliance with OSHA’s revised Hazard Communication Standard, including submission of Safety Data Sheets and GHS-compliant labeling prior to award. All packaging and labeling must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and palletization must follow DLA Packaging Requirements. The material must be shipped via traceable means only, with parcel post strictly prohibited. Deliveries are required within 30 days after award, with firm fixed pricing and zero variance allowed. Six separate shipments are specified to different military vessels and facilities across the U.S., each with unique delivery addresses,RDD codes, and projected receipt dates ranging from June to July 2026. The contract incorporates all applicable DLA Master List of Technical and Quality Requirements, which override ASTM D3951 where applicable, and includes mandatory clauses on veteran employment reporting and sustainable product sourcing.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE CLEANSPovidone-Iodine Cleansing Solution, USP, with 7.5% active ingredient, is procured for external use only in 1-gallon bottles identified by unit of issue BT, with a total shelf life of 36 months, requiring at least 31 months of remaining shelf life upon delivery to the first government activity. Storage must be maintained at 25°C (77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F). The product is regulated by the FDA and must comply with all applicable DLA Master List of Technical and Quality Requirements, including packaging standards under RP001 and labeling requirements consistent with MIL-STD-129 and Medical Marking Standard No. 1, which supersedes MIL-STD-129. All packaging must ensure protection from damage and safe transportation via commercial carrier at the lowest rate, and palletization must adhere to DLA requirements. The material is classified as hazardous under Fed-Std-313, necessitating Safety Data Sheets (SDS) formatted to OSHA’s Hazard Communication Standard and compliant labels per 29 C.F.R. 1910.1200, with supplier employee training mandatory. Shipping instructions vary by destination but mandate use of traceable transport methods; parcel post is strictly prohibited. Deliveries are scheduled for FPO addresses aboard U.S. Navy vessels, with six separate line items totaling 22 BT (10, 4, 2, 1, 1, and 4 gallons) required under firm fixed pricing, no quantity variance allowed, inspection and acceptance occurring at destination. Delivery must occur within 30 days after award date, with specific shipping dates ranging from March to May 2026. The solicitation number is SPE2DP-26-Q-0121, issued by the Department of Defense Medical Supply Chain, and incorporates clauses related to veteran employment reporting, sustainable products, and wide area workflow payment.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
CIPROFLOXACIN TABLETSCiprofloxacin tablets, 500 mg unit dose in packages of 100, are being procured under solicitation SPE2DP-26-T-4316 with the NSN 6505012738650, requiring a total of three units of issue, each representing 100 tablets. The item must comply with all technical and quality standards listed in the DLA Master List of Technical and Quality Requirements, including specific packaging guidelines that mandate commercial packaging consistent with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a container that protects against damage, and all shipments must be packed in commercial exterior containers suitable for safe delivery via common carrier at the lowest cost to the specified destination. The product has a non-extendable shelf life of 36 months and must bear labels and markings in full compliance with medical marking standards. The supplier, The Harvard Drug Group, L.L.C., must deliver the item FOB destination within 20 days of contract award, with no variance allowed in quantity. Inspection and acceptance occur at the delivery point, and all materials must be prepared in accordance with MIL-STD-2073-1E. The contract includes applicable defense information controls, and government identification must be removed from any non-accepted supplies. The solicitation opened on July 27, 2026, with a response deadline of August 3, 2026, and is being managed by the Department of Defense’s Medical Supply Chain PHARM FSA with direct contact through James Foggie.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
MECLIZINE HYDROCHLORIDMeclizine Hydrochloride Tablets USP, containing 25 milligrams of the active ingredient per tablet, are procured in bottles of 1,000 tablets, with a total shelf life of 24 months and a mandatory minimum of 21 months remaining at the time of receipt by the first government activity. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F) as per USP standards. Packaging must comply with commercial standards and meet the Medical Marking Standard No. 1, superseding MIL-STD-129, with all containers designed to prevent damage and ensure safe transport via common carrier at the lowest cost to the destination. The item is regulated by the FDA and requires referral to a product specialist for confirmation prior to award. The contract specifies delivery to Fort Bragg, North Carolina, within 20 days, with no variance allowed in quantity. The unit of issue is a bottle (BT), and palletization must follow DLA packaging requirements. The drug is supplied by approved manufacturers including Amneal Pharmaceuticals and Jubilant Cadista, with NDC identifiers provided. The material is not classified as hazardous per Fed-Std-313 and must be commercially packaged in accordance with ASTM D3951, though DLA’s Master List of Technical and Quality Requirements takes precedence. Shipments must be traceable and不得 use parcel post. The solicitation number is SPE2DP-26-T-4296, with a response deadline of August 3, 2026, and the required delivery date is July 28, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
ACYCLOVIR TABLETSThe contract pertains to the procurement of 3 bottles of 800 mg acyclovir tablets, each bottle containing 100 tablets, under solicitation SPE2DP-26-T-4323, with delivery required within 20 days FOB destination. The product must meet strict packaging standards as defined by Medical Marking Standard No. 1, superseding MIL-STD-129, and must be packed in sealed unit containers that prevent damage, with exterior shipping containers ensuring safe, cost-effective delivery via common carrier. The acyclovir tablets are sourced from approved manufacturers including Golden State, Teva, GSK Zovirax, Carlsbad Tech, and Mylan, each identified by specific NDC codes. The item carries a non-extendable 24-month shelf life as a Type I (Code M) item, and no mercury or mercury-containing compounds may be introduced into the product or packaging, except for specific exceptions such as batteries or instruments meeting NAVSEA specifications. The contract follows DLA’s master list of technical and quality requirements, and units must be marked in accordance with DLA’s medical marking guidelines. Inspection and acceptance occur at the delivery point with zero variance allowed in quantity, and the unit of issue is bottles (BT). The contract is issued under the Department of Defense, with performance located at Fort Bragg, and all documentation must align with DoD authorized unit of issue standards.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATIONThe contract is for a topical sunscreen preparation containing 4.5% titanium dioxide and 4% zinc oxide with an SPF of 50, designed for outdoor use and labeled as sweat and water-resistant for 80 minutes, hypoallergenic, oil-free, PABA-free, and biodegradable. Each unit of issue is a package containing 24 tubes of 3 ounces, with a total shelf life of 24 months and a minimum of 21 months remaining at time of delivery to the first government activity. Storage must be maintained between 15°C and 30°C (59°F and 86°F) in a cool, dry environment. The product is regulated by the FDA and must comply with all DLA Master List of Technical and Quality Requirements, which take precedence over commercial standards like ASTM D3951. Packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and all units must be sealed and shipped in commercially appropriate containers that ensure safe delivery via common carrier at the lowest cost to the specified delivery points. Palletization must follow DLA packaging requirements, and shipment must occur by the fastest traceable means, excluding parcel post. The material is not classified as hazardous under FED-STD-313, so commercial packaging per ASTM D3951 applies unless overridden by stricter DLA requirements. Three separate delivery line items exist, totaling four pallets, with delivery addresses at military installations in Massachusetts, North Carolina, and aboard the USS Gridley via FPO. All deliveries are FOB destination with zero quantity variance, inspected and accepted at the delivery point, with required delivery dates ranging from July 29 to July 30, 2026. The solicitation number is SPE2DP-26-T-4340, with a response deadline of August 3, 2026.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
PHENYLEPHRINE HYDROThe contract specifies the procurement of Phenylephrine Hydrochloride Ophthalmic Solution USP 2.5% in 10 mL sterile, aqueous, topical bottles manufactured by Bausch & Lomb Americas Inc. with NDC 82260-0102-10, to be delivered in a quantity of six bottles under solicitation SPE2DP-26-T-4342. The product must be stored at 2°C to 25°C (36°F to 77°F) and packaged in sealed unit containers that protect against damage, with all outer shipping containers meeting commercial standards for safe transport by common carrier at the lowest cost to the designated destination in Williamsburg, VA. Packaging and marking must comply with Medical Marking Standard No. 1, replacing all references to MIL-STD-129, and palletization must follow DLA Packaging Requirements for Procurement. The item has a non-extendable shelf life of 24 months as a TYPE I (CODE M) product and must be labeled accordingly. The solution is contained in opaque white LDPE bottles with LLDPE dropper tips and red caps, and the entire shipment must be delivered FOB destination within five days of the order. Shipment must be sent by the fastest traceable means; parcel post is prohibited. Delivery is required by April 15, 2026, with inspection and acceptance occurring at the destination point. The National Stock Number is 6505017090360 and the purchase request number is 7016297029. The item is regulated by the FDA, requiring a referral to the product specialist through EBS with full bidder and manufacturer details. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with the revision in effect on the solicitation issue date controlling. Contract-specific identifiers, including CLIN, pricing, and unit of issue, are structured under the DoD authorized unit of issue system, and all documentation must reflect current DLA standards for marking, packaging, and logistics. The point of contact for inquiries is James Mariani of the Department of Defense Medical Supply Chain.
Medicinal and Botanical Manufacturing

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
VERAPAMIL HYDROCHLORIDVerapamil hydrochloride injection is a 5 mg per 2 mL solution packaged in 2 mL single-dose glass fliptop vials, supplied in packs of 25, and is preservative-free for intravenous use only. The product must be protected from light and stored at controlled room temperature between 20 to 25°C (68 to 77°F), conforming to USP standards. It has a non-extendable shelf life of 24 months from the date of manufacture, and no more than four months may have elapsed between manufacture and delivery to the government. The item is identified by NSN 6505-01-738-0226 and is subject to stringent technical and quality requirements as defined in the DLA Master List, with packaging and handling governed by DLA procurement standards. Government identification must be removed from non-accepted supplies, and covered defense information provisions apply. The solicitation, issued under SPE2DP-26-T-4330 on July 28, 2026, with a response deadline of August 3, 2026, is for a federal procurement through the Department of Defense’s Medical Supply Chain PHARM FSA, with delivery required within five days of award, and the point of contact is Daniel Porter at daniel.porter@dla.mil.
Medicinal and Botanical Manufacturing

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details
NAICS: 423450
New
DIBBS
ATROPINE SULFATE INAtropine Sulfate Injection, USP, is a sterile, nonpyrogenic, preservative-free, and non-DEHP product supplied in a 5 mL single-dose syringe with a 20-gauge by 1.5-inch protected needle featuring a male Luer lock adapter. Each milliliter contains 0.1 mg of atropine sulfate monohydrate and 9 mg of sodium chloride, resulting in a total of 0.5 mg of atropine per syringe. The medication is indicated for subcutaneous, intramuscular, or intravenous administration and is labeled RX only. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F) and has a non-extendable shelf life of 24 months. Packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and all DLA Master List of Technical and Quality Requirements take precedence over commercial packaging standards. The product is regulated by the FDA and is supplied by Pfizer Inc with NDC code 00409-4910-34. The contract, issued under solicitation number SPE2DP-26-T-4325, requires delivery of one pallet (PG) containing ten units to Fort Bragg, North Carolina, within 20 days of order placement, FOB destination. No quantity variance is permitted, and inspection and acceptance occur at the delivery point. The material is not classified as hazardous under FED-STD-313 and must be commercially packaged in accordance with ASTM D3951, unless overridden by DLA requirements. All packaging must be marked and labeled per DLA specifications, palletized as per RP001, and shipped via traceable means, excluding parcel post. The delivery is mandated for July 29, 2026, with the contract awarded to the Department of Defense, Medical Supply Chain Pharm FSA, and all technical, quality, and packaging specifications are governed by the DLA Master List in effect on the solicitation issue date. A referral must be sent via EBS to confirm bidder and manufacturer details prior to award.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
DIETARY SUPPLEMENT, THEThe product is an unflavored therapeutic dietary supplement in powder form, packaged in 80-gram units, with each packet reconstituted to yield 8 to 10 ounces of liquid. It is lactose-free and supplied in packages containing six individual units, with a unit of issue defined as a package. Each package must have an 18-month shelf life from the date of manufacture, and no more than three months may elapse between the manufacture date and delivery to the government. Packaging must comply with commercial standards as specified, using sealed unit containers to protect contents from damage, and exterior shipping containers must ensure safe, cost-effective delivery via common carriers. Labeling and marking must follow Medical Marking Standard No. 1, superseding MIL-STD-129, and palletization must adhere to DLA Packaging Requirements for Procurement. All technical and quality requirements from the DLA Master List take precedence over ASTM D3951. The item is subject to firm fixed pricing with zero variance in quantity, inspection and acceptance occur at destination, and delivery is due within 35 days after order date. Shipping must be via traceable freight methods only, not parcel post, with specified delivery addresses for two distinct locations. The contract includes clauses related to veteran employment reporting, sustainable product procurement, and Wide Area Workflow payment processing. The National Stock Number is 8940-01-317-9838, and the solicitation number is SPE2DP-26-Q-0125.
Medicinal and Botanical Manufacturing

POSTED

about 7 hours ago

DEADLINE

in 8 days
View Details
NAICS: 423450
New
DIBBS
LIDOCAINE HYDROCHLOLidocaine Hydrochloride and Epinephrine, USP, is a parenteral injectable pharmaceutical product containing a 2 percent concentration of lidocaine hydrochloride and a 1:50,000 dilution of epinephrine bitartrate, supplied in 1.7 mL single-dose cartridges. Each unit of issue consists of a package of 50 cartridges, organized in five blisters of ten per cardboard box. The product must be stored at controlled room temperature below 25°C (77°F), protected from light, and must not be frozen. It is regulated by the FDA and has a non-extendable shelf life of 18 months as a Type I (Code K) item. Packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure the product is sealed, protected from damage, and shipped in suitable commercial containers to guarantee safe delivery. Technical and quality requirements referenced in the document are governed by the DLA Master List of Technical and Quality Requirements, with revisions controlled based on solicitation or award date depending on acquisition type. This procurement is issued under Solicitation Number SPE2DP-26-T-4333 by the Department of Defense’s Medical Supply Chain Pharm FSA. One pack (PG) of 50 cartridges is required, with a delivery requirement of five days after award, delivered FOB destination to JBER, Alaska. The NSN is 6505-01-576-2767 and the purchase request number is 7017631646. The product must be supplied by an approved manufacturer with part number NDC66312-0181-16 or equivalent, and shipment must adhere to all DLA packaging standards, including commercial packaging for medical items and specific marking requirements. No quantity variance is permitted, and inspection and acceptance occur at the destination. The required delivery date is July 29, 2026, and the response deadline for the solicitation is August 3, 2026. The contracting officer must submit a referral in EBS for confirmation, including manufacturer and bidder details. Transportation and delivery logistics are governed by DLA procedural notes C19 and C20, with the point of contact for inquiries being Timothy McCauley.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325620
New
DIBBS
SUNSCREEN AND INSECT RThe contract specifies the procurement of a 4 oz spray bottle containing SPF 30 sunscreen and an all-natural insect repellent, packaged in units of 12 per package, with a non-extendable shelf life of 36 months as required for a Type I (Code Q) item. All packaging, marking, and labeling must comply with the Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure the product is protected from damage during transit while meeting commercial packaging standards. The item is classified as flammable/combustible, triggering adherence to Hazard Communication Standard requirements under 29 C.F.R. 1910.1200, which mandates submission of Safety Data Sheets and compliant labels prior to award, along with employee training on hazard communication protocols. The product must be delivered FOB destination within 20 days of contract award, with no tolerance for quantity variance, and must be shipped via traceable means excluding parcel post to the delivery location at Fort Bragg, North Carolina. Packaging and palletization must follow DLA’s official procurement standards, and all technical and quality requirements referenced by R or I numbers are binding as defined in the DLA Master List. The contract number is SPE2DP-26-T-4326, the NSN is 6505-01-600-3398, and the required delivery date is July 29, 2026.
Toilet Preparation Manufacturing

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details
NAICS: 423450
New
DIBBS
TOLNAFTATE CREAMTolnaftate Cream, USP, is a 1% topical antifungal cream supplied in tubes containing 15 grams each, with the unit of issue being a tube (TU). The product has a total shelf life of 36 months, and at the time of receipt by the first government activity, there must be a minimum of 31 months of remaining shelf life. It must be stored at controlled room temperature between 20-25°C (68-77°F), with short-term excursions allowed between 15-30°C (59-86°F) in accordance with USP standards. The cream is manufactured by Taro Pharmaceuticals U.S.A., Inc., with NDC 51672-2020-01, and is regulated by the FDA. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with specific references to RA001, RP001, RQ001, RS020, and RS001, which mandate compliance with FDA and DoD packaging, labeling, and shelf-life protocols. The product must be packaged in accordance with Commercial Packaging Standards as specified in the procurement document, with each unit sealed in a protective container and shipped in suitable exterior containers to ensure safe delivery via commercial carrier at the lowest rate to the designated destination. Packaging and marking must adhere strictly to Medical Marking Standard No. 1, superseding MIL-STD-129, and all labels must include required government identifiers. The shipment of 20 tubes is to be delivered FOB destination within 20 days, with no quantity variance permitted. Transportation must be via traceable means, excluding parcel post, and the item is to be delivered to the specified location in Bogalusa, Louisiana. The contract requires confirmation through EBS referral to the product specialist, ensuring proper vendor and manufacturer validation prior to award, and all documentation must comply with DLA’s acquisition and logistics directives, including palletization and hazardous material standards where applicable.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
SUMATRIPTAN SUCCINATESumatriptan Succinate Tablets, 100 mg in bottles of nine tablets, are procured under contract SPE2DP-26-T-4339 for acute treatment of migraines with or without aura in adults. The product must be stored at 20 to 25°C (68 to 77°F), protected from light, and carries a non-extendable 24-month shelf life as a Type I (Code M) item. Packaging and labeling must comply with MIL-STD-2073-1E, MIL-STD-129, and the latest Medical Marking Standard No. 1, with palletization following DLA Packaging Requirements. The item is regulated by the FDA and requires confirmation via EBS referral before award. Delivery is FOB destination within five days, with zero quantity variance allowed, and inspection and acceptance occur at the delivery point. Three separate CLINs specify delivery to APO AE 09094-3219 and JBER AK 99506, with total quantities of one bottle each for two entries and five bottles for the third, all under the same NSN 6505017278704. The contract references DLA technical and quality requirements, including RD003 for covered defense information, and mandates adherence to specified marking and shipping protocols. The solicitation was posted on July 28, 2026, with a response deadline of August 3, 2026, and required delivery dates range from July 29 to July 30, 2026.
Medicinal and Botanical Manufacturing

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details